Bausch + Lomb Corporation (BLCO)
NYSE: BLCO · Real-Time Price · USD
13.50
-0.13 (-0.95%)
Aug 1, 2025, 4:00 PM - Market closed
United States Steel Revenue
Bausch + Lomb had revenue of $1.28B in the quarter ending June 30, 2025, with 5.10% growth. This brings the company's revenue in the last twelve months to $4.89B, up 8.81% year-over-year. In the year 2024, Bausch + Lomb had annual revenue of $4.79B with 15.56% growth.
Revenue (ttm)
$4.89B
Revenue Growth
+8.81%
P/S Ratio
0.97
Revenue / Employee
$362,296
Employees
13,500
Market Cap
4.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.79B | 645.00M | 15.56% |
| Dec 31, 2023 | 4.15B | 378.00M | 10.03% |
| Dec 31, 2022 | 3.77B | 3.00M | 0.08% |
| Dec 31, 2021 | 3.77B | 353.00M | 10.35% |
| Dec 31, 2020 | 3.41B | -366.00M | -9.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
BLCO News
- 2 days ago - Bausch + Lomb Corporation (BLCO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Bausch + Lomb Announces Second-Quarter 2025 Results - Business Wire
- 4 weeks ago - Bausch + Lomb Combines Patient Voices and New Survey Insights to Combat Persistent Misconceptions about Dry Eye - Business Wire
- 4 weeks ago - Bausch + Lomb Will Release Second-Quarter 2025 Financial Results on July 30 and Hold Investor Day on Nov. 13 - Business Wire
- 6 weeks ago - Bausch + Lomb Announces Pricing of Upsized Senior Secured Notes Offering - Business Wire
- 6 weeks ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Bausch + Lomb Corporation (BLCO) And Encourages Investors to Connect - Accesswire
- 6 weeks ago - Bronstein, Gewirtz & Grossman, LLC Encourages Bausch + Lomb Corporation (BLCO) Stockholders to Inquire about Securities Investigation - Accesswire
- 6 weeks ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Bausch + Lomb Corporation (BLCO) and Encourages Investors to Learn More About the Investigation - Accesswire